| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aecb5d203a63cdb920c41dbf7a44925e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate |
2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad50b010176763fff4737ddb6bfe0bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480957558d18a1bac9cb33d2acf9e1a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6641cdb012bf4ca5ade48638681b9100
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bcb0c5afb49d59e36a34055aef72955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3501d958dea02b3706546bae3384d003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a2222d4fd66f890781e90f50fb196d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11630b999d294e4c07dc9d4cd7b8319f |
| publicationDate |
2013-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2013000545-A |
| titleOfInvention |
PHARMACEUTICAL COMPOSITIONS AND TREATMENT METHODS. |
| abstract |
The present invention provides pharmaceutical compositions consisting of an activated and enhanced formulation of an antibody to the human cannabinoid receptor and its use in the treatment of obesity and related metabolic disorders. The present invention also provides pharmaceutical compositions consisting of an activated and enhanced formulation of an antibody to the human cannabinoid receptor and an activated and enhanced formulation of an antibody to the S-100 protein, to be used in the treatment of substance addiction. Psychoactive The present invention provides methods for treating obesity and related metabolic disorders, as well as drug addiction. |
| priorityDate |
2010-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |